These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 25887381

  • 1. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
    Cioffi M, Trabulo SM, Sanchez-Ripoll Y, Miranda-Lorenzo I, Lonardo E, Dorado J, Reis Vieira C, Ramirez JC, Hidalgo M, Aicher A, Hahn S, Sainz B, Heeschen C.
    Gut; 2015 Dec; 64(12):1936-48. PubMed ID: 25887381
    [Abstract] [Full Text] [Related]

  • 2. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK, Mondal G, Kumar V, Kattel K, Mahato RI.
    Cancer Lett; 2017 Aug 28; 402():1-8. PubMed ID: 28536008
    [Abstract] [Full Text] [Related]

  • 3. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
    Yang Z, Zhao N, Cui J, Wu H, Xiong J, Peng T.
    Cell Oncol (Dordr); 2020 Feb 28; 43(1):123-136. PubMed ID: 31713003
    [Abstract] [Full Text] [Related]

  • 4. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells.
    Vaz AP, Ponnusamy MP, Rachagani S, Dey P, Ganti AK, Batra SK.
    Br J Cancer; 2014 Jul 29; 111(3):486-96. PubMed ID: 25003666
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal.
    Pan Y, Li K, Tao X, Zhao Y, Chen Q, Li N, Liu J, Go VLW, Guo J, Gao G, Xiao GG.
    Pancreas; 2021 Oct 01; 50(9):1260-1266. PubMed ID: 34860809
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.
    Dhayat SA, Mardin WA, Seggewiß J, Ströse AJ, Matuszcak C, Hummel R, Senninger N, Mees ST, Haier J.
    PLoS One; 2015 Oct 01; 10(11):e0143755. PubMed ID: 26606261
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.
    Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH.
    Cancer Prev Res (Phila); 2012 Mar 01; 5(3):355-64. PubMed ID: 22086681
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
    Xian G, Zhao J, Qin C, Zhang Z, Lin Y, Su Z.
    Cancer Lett; 2017 Jan 28; 385():65-74. PubMed ID: 27840243
    [Abstract] [Full Text] [Related]

  • 11. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
    Niess H, Camaj P, Renner A, Ischenko I, Zhao Y, Krebs S, Mysliwietz J, Jäckel C, Nelson PJ, Blum H, Jauch KW, Ellwart JW, Bruns CJ.
    Target Oncol; 2015 Jun 28; 10(2):215-27. PubMed ID: 24950733
    [Abstract] [Full Text] [Related]

  • 12. Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma.
    Aboukameel A, Muqbil I, Senapedis W, Baloglu E, Landesman Y, Shacham S, Kauffman M, Philip PA, Mohammad RM, Azmi AS.
    Mol Cancer Ther; 2017 Jan 28; 16(1):76-87. PubMed ID: 28062705
    [Abstract] [Full Text] [Related]

  • 13. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
    Yao J, An Y, Wie JS, Ji ZL, Lu ZP, Wu JL, Jiang KR, Chen P, Xu ZK, Miao Y.
    Swiss Med Wkly; 2011 Jan 28; 141():w13208. PubMed ID: 21630164
    [Abstract] [Full Text] [Related]

  • 14. Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma.
    Ma L, Fan Z, Du G, Wang H.
    Biochem Biophys Res Commun; 2019 Feb 12; 509(3):845-853. PubMed ID: 30638935
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.
    Isayev O, Rausch V, Bauer N, Liu L, Fan P, Zhang Y, Gladkich J, Nwaeburu CC, Mattern J, Mollenhauer M, Rückert F, Zach S, Haberkorn U, Gross W, Schönsiegel F, Bazhin AV, Herr I.
    Oncotarget; 2014 Jul 15; 5(13):5177-89. PubMed ID: 25015789
    [Abstract] [Full Text] [Related]

  • 16. Gemcitabine Enhances Kras-MEK-Induced Matrix Metalloproteinase-10 Expression Via Histone Acetylation in Gemcitabine-Resistant Pancreatic Tumor-initiating Cells.
    Shimizu K, Nishiyama T, Hori Y.
    Pancreas; 2017 Feb 15; 46(2):268-275. PubMed ID: 28060183
    [Abstract] [Full Text] [Related]

  • 17. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
    Sainz B, Alcala S, Garcia E, Sanchez-Ripoll Y, Azevedo MM, Cioffi M, Tatari M, Miranda-Lorenzo I, Hidalgo M, Gomez-Lopez G, Cañamero M, Erkan M, Kleeff J, García-Silva S, Sancho P, Hermann PC, Heeschen C.
    Gut; 2015 Dec 15; 64(12):1921-35. PubMed ID: 25841238
    [Abstract] [Full Text] [Related]

  • 18. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H, Gao W, Li X, Yu L, Luo D, Liu Y, Yu X.
    Pancreatology; 2021 Apr 15; 21(3):589-598. PubMed ID: 33579599
    [Abstract] [Full Text] [Related]

  • 19. BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling.
    Liu X, Tian X, Wang F, Ma Y, Kornmann M, Yang Y.
    Eur J Cancer; 2014 Sep 15; 50(13):2251-62. PubMed ID: 24953335
    [Abstract] [Full Text] [Related]

  • 20. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Nimmakayala RK, Leon F, Rachagani S, Rauth S, Nallasamy P, Marimuthu S, Shailendra GK, Chhonker YS, Chugh S, Chirravuri R, Gupta R, Mallya K, Prajapati DR, Lele SM, C Caffrey T, L Grem J, Grandgenett PM, Hollingsworth MA, Murry DJ, Batra SK, Ponnusamy MP.
    Oncogene; 2021 Jan 15; 40(1):215-231. PubMed ID: 33110235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.